Social Security Disability Insurance (SSDI) in Parkinson’s disease.
Zesiewicz, TA, A Patel-Larson, RA Hauser, and KL Sullivan. 2007. “Social Security Disability Insurance (SSDI) in Parkinson’s Disease.”. Disabil Rehabil.
Search
Search results
2106 results found
Levodopa-induced dyskinesia in Parkinson’s disease: epidemiology, etiology, and treatment.
Zesiewicz, TA, CL Ward, RA Hauser, JL Salemi, S Siraj, MC Wilson, and KL Sullivan. 2007. “Levodopa-Induced Dyskinesia in Parkinson’s Disease: Epidemiology, Etiology, and Treatment.”. Curr Neurol Neurosci Rep .
Chorea induced by lamotrigine.
Zesiewicz, TA, KL Sullivan, and RA Hauser. 2006. “Chorea Induced by Lamotrigine.”. J Child Neurol.
Vascular hemichorea/hemiballismus and topiramate.
Zesiewicz, TA, KL Sullivan, and RA Hauser. 2006. “Vascular Hemichorea/Hemiballismus and Topiramate.”. Movement Disorders.
Long-term evaluation of deep brain stimulation of the thalamus.
Pahwa, R, KE Lyons, SB Wilkinson, RK Simpson Jr, WG Ondo, RA Hauser, and . 2006. “Long-Term Evaluation of Deep Brain Stimulation of the Thalamus.”. J Neurosurg.
Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson’s disease. Movement Disorders 2005;20:1205-1209.
Zesiewicz, TA, KL Sullivan, JL Maldonado, and RA Hauser. 2005. “Open-Label Pilot Study of Levetiracetam (Keppra) for the Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease. Movement Disorders 2005;20:1205-1209.”. Movement Disorders.
Ropinirole for Restless Legs Syndrome: A Placebo-Controlled Crossover Trial. Neurology 2004;62:1405-1407.
Adler, CH, RA Hauser, K Sethi, JN Caviness, L Marlor, M Anderson, and JG Hentz. 2004. “Ropinirole for Restless Legs Syndrome: A Placebo-Controlled Crossover Trial. Neurology 2004;62:1405-1407.”. Neurology.
Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorder. Hum Genet 2003;113:154-161.
Crawford, FC, G Ait-Ghezala, M Morris, MJ Sutcliffe, RA Hauser, AA Silver, and MJ Mullan. 2003. “Translocation Breakpoint in Two Unrelated Tourette Syndrome Cases, Within a Region Previously Linked to the Disorder. Hum Genet 2003;113:154-161.”. Hum Genet.
Clozapine withdrawal symptoms in a Parkinson’s disease patient. Movement Disorders 2002;17:1365-1367.
Zesiewicz, TA, S Borra, and RA Hauser. 2002. “Clozapine Withdrawal Symptoms in a Parkinson’s Disease Patient. Movement Disorders 2002;17:1365-1367.”. Movement Disorders.
Carboxymethyl Chitosan Microgels for Sustained Delivery of Vancomycin and Long-Lasting Antibacterial Effects
Sahiner, Mehtap, Aynur S. Yilmaz, Ramesh S. Ayyala, and Nurettin Sahiner. 2023. “Carboxymethyl Chitosan Microgels for Sustained Delivery of Vancomycin and Long-Lasting Antibacterial Effects”. Gels 9 (9).